Your browser doesn't support javascript.
loading
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer.
Kojima, Takashi; Shah, Manish A; Muro, Kei; Francois, Eric; Adenis, Antoine; Hsu, Chih-Hung; Doi, Toshihiko; Moriwaki, Toshikazu; Kim, Sung-Bae; Lee, Se-Hoon; Bennouna, Jaafar; Kato, Ken; Shen, Lin; Enzinger, Peter; Qin, Shu-Kui; Ferreira, Paula; Chen, Jia; Girotto, Gustavo; de la Fouchardiere, Christelle; Senellart, Helene; Al-Rajabi, Raed; Lordick, Florian; Wang, Ruixue; Suryawanshi, Shailaja; Bhagia, Pooja; Kang, S Peter; Metges, Jean-Philippe.
Afiliação
  • Kojima T; National Cancer Center Hospital East, Kashiwa, Japan.
  • Shah MA; Weill Cornell Medical College, New York, NY.
  • Muro K; Aichi Cancer Center Hospital, Nagoya, Japan.
  • Francois E; CLCC Antoine Lacassagne, Nice, France.
  • Adenis A; IRCM, Inserm, Université Montpellier, ICM, Montpellier, France.
  • Hsu CH; National Taiwan University Hospital, Taipei, Taiwan.
  • Doi T; National Cancer Center Hospital East, Chiba, Japan.
  • Moriwaki T; University of Tsukuba Hospital, Tsukuba, Japan.
  • Kim SB; Asan Medical Center, Seoul, South Korea.
  • Lee SH; Samsung Medical Center, Seoul, South Korea.
  • Bennouna J; Institut de Cancerologie de L'Ouest, Nantes, France.
  • Kato K; National Cancer Center Hospital, Tokyo, Japan.
  • Shen L; Beijing Cancer Hospital, Beijing, China.
  • Enzinger P; Dana Farber Cancer Institute and Harvard Medical School, Boston, MA.
  • Qin SK; PLA Cancer Centre of Nanjing Bayi Hospital, Nanjing, China.
  • Ferreira P; Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E., Porto, Portugal.
  • Chen J; Jiangsu Cancer Hospital, Nanging, China.
  • Girotto G; Hospital de Base de Sao Jose do Rio Preto, Sao Jose do Rio Preto, Brazil.
  • de la Fouchardiere C; Centre Leon Berard, Lyon, France.
  • Senellart H; Centre Rene Gauducheau ICO, Saint Herblain, France.
  • Al-Rajabi R; University of Kansas Cancer Center, Westwood, KS.
  • Lordick F; University Cancer Center Leipzig, Leipzig, Germany.
  • Wang R; Merck & Co, Inc, Kenilworth, NJ.
  • Suryawanshi S; Merck & Co, Inc, Kenilworth, NJ.
  • Bhagia P; Merck & Co, Inc, Kenilworth, NJ.
  • Kang SP; Merck & Co, Inc, Kenilworth, NJ.
  • Metges JP; CHU Brest - Institut de Cancerologie et d'Hematologie, Arpego Network, Brest, France.
J Clin Oncol ; 38(35): 4138-4148, 2020 12 10.
Article em En | MEDLINE | ID: mdl-33026938
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article